RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis

Cancer Research

Volumn 71, Issue 21, 2011, Pages 6708-6717

  Saporita, Anthony J ^a   Chang, Hsiang Chun ^a   Winkeler, Crystal L ^a   Apicelli, Anthony J ^a   Kladney, Raleigh D ^a   Wang, Jianbo ^a   Townsend, R Reid ^b   Michel, Loren S ^a   Weber, Jason D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; NUCLEOPHOSMIN; PROTEIN DDX5; PROTEIN P53; RIBOSOME DNA; RIBOSOME RNA; RNA HELICASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOGENESIS; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEOMICS; RIBOSOME; RNA SYNTHESIS; TUMOR GROWTH;

ANIMALS; CELL DIVISION; CELL NUCLEOLUS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DEAD-BOX RNA HELICASES; DNA, RIBOSOMAL; FIBROBLASTS; MICE; MICE, KNOCKOUT; MICE, NUDE; NUCLEAR PROTEINS; ONCOGENE PROTEIN P21(RAS); PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; RIBOSOMES; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, RIBOSOMAL; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80155192723     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1472     Document Type: Article

References (40)

1. Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004;24:985-96. (Pubitemid 38112164)
2. Rizos H, McKenzie HA, Ayub AL, Woodruff S, Becker TM, Scurr LL, et al. Physical and functional interaction of the p14ARF tumor suppressor with ribosomes. J Biol Chem 2006;281:38080-8. (Pubitemid 46042111)
3. Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, Steen H, et al. Directed proteomic analysis of the human nucleolus. Curr Biol 2002;12:1-11.
4. Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, et al. Nucleolar proteome dynamics. Nature 2005;433:77-83. (Pubitemid 40101146)
5. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 1998;95:8292-7. (Pubitemid 28326106)
6. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999;1:20-6. (Pubitemid 129495005)
7. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-23. (Pubitemid 28155311)
8. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998;92:725-34. (Pubitemid 28155312)
9. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91:649-59. (Pubitemid 27513656)
10. Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ. Tumor spectrum in ARF-deficient mice. Cancer Res 1999;59:2217-22. (Pubitemid 29217688)
11. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, et al. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev 2000;14:2358-65.
12. Apicelli AJ, Maggi LB Jr, Hirbe AC, Miceli AP, Olanich ME, Schulte- Winkeler CL, et al. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Mol Cell Biol 2008;28: 1068-80. (Pubitemid 351160063)
13. Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, et al. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol 2005;25:8874-86. (Pubitemid 41429079)
14. Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW, et al. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 2005;25:1258-71. (Pubitemid 40204905)
15. Brady SN, Yu Y, Maggi LB Jr, Weber JD. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. Mol Cell Biol 2004;24:9327-38. (Pubitemid 39391671)
16. Enomoto T, Lindstrom MS, Jin A, Ke H, Zhang Y. Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability. J Biol Chem 2006;281:18463-72. (Pubitemid 44035505)
17. Rocak S, Linder P. DEAD-box proteins: the driving forces behind RNA metabolism. Nat Rev Mol Cell Biol 2004;5:232-41. (Pubitemid 38325804)
18. Fuller-Pace FV. DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res 2006;34:4206-15. (Pubitemid 44542200)
19. Yang Q, Del Campo M, Lambowitz AM, Jankowsky E. DEAD-box proteins unwind duplexes by local strand separation. Mol Cell 2007;28:253-63. (Pubitemid 47610740)
20. Bleichert F, Baserga SJ. The long unwinding road of RNA helicases. Mol Cell 2007;27:339-52. (Pubitemid 47126943)
21. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer 2003;3:179-92. (Pubitemid 37328870)
22. Palmero I, Pantoja C, Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature 1998;395:125-6. (Pubitemid 28425643)
23. Zindy F, EischenCM,RandleDH,Kamijo T, Cleveland JL,Sherr CJ, et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998;12:2424-33. (Pubitemid 28371361)
24. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev 1998;12:2434-42. (Pubitemid 28371362)
25. Bredemeyer AJ, Lewis RM, Malone JP, Davis AE, Gross J, Townsend RR, et al. A proteomic approach for the discovery of protease substrates. Proc Natl Acad Sci U S A 2004;101:11785-90. (Pubitemid 39095372)
26. Maggi LB Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, et al. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol Cell Biol 2008;28:7050-65.
27. Pelletier CL, Maggi LB Jr, Brady SN, Scheidenhelm DK, Gutmann DH, Weber JD. TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation. Cancer Res 2007;67:1609-17. (Pubitemid 46383386)
28. Ayrault O, Andrique L, Fauvin D, Eymin B, Gazzeri S, Seite P. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation. Oncogene 2006; 25:7577-86. (Pubitemid 44924471)
29. Lessard F, Morin F, Ivanchuk S, Langlois F, Stefanovsky V, Rutka J, et al. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I. Mol Cell 2010;38:539-50.
30. O'Sullivan AC, Sullivan GJ, McStay B. UBF binding in vivo is not restricted to regulatory sequences within the vertebrate ribosomal DNA repeat. Mol Cell Biol 2002;22:657-68. (Pubitemid 34027509)
31. Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 2007;9:604-11. (Pubitemid 46696543)
32. Jalal C, Uhlmann-Schiffler H, Stahl H. Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Res 2007;35:3590-601. (Pubitemid 47244654)
33. Bates GJ, Nicol SM, Wilson BJ, Jacobs AM, Bourdon JC, Wardrop J, et al. The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. EMBO J 2005;24:543-53. (Pubitemid 40343256)
34. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009;460: 529-33.
35. Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 2003;11: 415-24. (Pubitemid 36293835)
36. Murano K, Okuwaki M, Hisaoka M, Nagata K. Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity. Mol Cell Biol 2008;28:3114-26. (Pubitemid 351657078)
37. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005;437:147-53. (Pubitemid 41613442)
38. Yu Y, Maggi LB Jr, Brady SN, Apicelli AJ, Dai MS, Lu H, et al. Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol 2006;26:3798-809. (Pubitemid 43726397)
39. Jensen ED, Niu L, Caretti G, Nicol SM, Teplyuk N, Stein GS, et al. p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation. J Cell Biochem 2008;103:1438-51. (Pubitemid 351490713)
40. Luo J, Solimini NL, Elledge SJ. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009;136:823-37.